WELLTRUST™, a patient consent database managed by WELL Health Technologies, has exceeded 100,000 consents since its launch in February 2026. The platform uses HEALWELL's DARWEN™ AI to match patients with clinical trials, improving recruitment speed and precision by leveraging real-time clinical data and patient consent captured via OceanMD. This milestone was achieved organically through in-clinic enrollment, with plans to expand consent capture digitally and scale toward one million consented patients. The initiative aims to streamline clinical trial recruitment, reducing delays and enhancing access to lifesaving research.
A class action lawsuit has been filed against Celsius Holdings, Inc. for allegedly misleading investors about the safety of its Alani Nu energy drinks, which contain high caffeine levels unsafe for teenagers. The suit follows reports linking the drin...
Lenovo Group is rapidly evolving from a traditional PC maker into a leading AI and data center infrastructure provider, driving strong stock momentum. The company reported a record Q2 revenue of $26.94 billion, up 43.1% year-over-year, with adjusted ...
Protalix BioTherapeutics announced that its CFO, Gilad Mamlok, will participate in two key investor events in New York City from September 14-16, 2026. He will present at the H.C. Wainwright 28th Annual Global Investment Conference and join a firesid...
Seattle-based WaFd Bank and digital lender EverBank have agreed to merge in a $3.9 billion deal, creating a larger bank named EverBank Financial that will trade under the ticker EVBK. The merger combines WaFd's extensive branch network and commercial...
Ferrexpo PLC obtained a $15 million unsecured loan from its largest shareholder, Fevamotinico, to boost liquidity before a planned $100 million equity raise. The loan, with a 9.75% interest rate and 12-month maturity, supports working capital and pro...
